SEC 13F Intelligence

Aviva Holdings Ltd. / MRTXEUR

Aviva Holdings Ltd.’s Mirati Therapeutics Inc Position

Does Aviva Holdings Ltd. own Mirati Therapeutics Inc (MRTXEUR)? Not currently — the last reported position was 3.14M shares worth $137M in Q3 2023; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$137M
Q3 2023
Shares
3.14M
% of Portfolio
+87.83%
Quarters Held
20
position exited

Position History MRTXEUR

Reported value by quarter
Q4 ’18: $133MQ4 ’18Q1 ’19: $230MQ2 ’19: $323MQ3 ’19: $244MQ3 ’19Q4 ’19: $369MQ1 ’20: $241MQ2 ’20: $358MQ2 ’20Q3 ’20: $521MQ4 ’20: $689MQ1 ’21: $537MQ1 ’21Q2 ’21: $507MQ3 ’21: $555MQ4 ’21: $460MQ4 ’21Q1 ’22: $258MQ2 ’22: $211MQ3 ’22: $219MQ3 ’22Q4 ’22: $142MQ1 ’23: $117MQ2 ’23: $113,302Q2 ’23Q3 ’23: $137Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20233.14M$137M+87.83%
Q2 20233.14M$113,302+82.86%
Q1 20233.14M$117M+81.37%
Q4 20223.14M$142M+81.47%
Q3 20223.14M$219M+79.20%
Q2 20223.14M$211M+75.77%
Q1 20223.14M$258M+68.01%
Q4 20213.14M$460M+74.85%
Q3 20213.14M$555M+78.28%
Q2 20213.14M$507M+69.99%
Q1 20213.14M$537M+71.40%
Q4 20203.14M$689M+67.42%
Q3 20203.14M$521M+67.85%
Q2 20203.14M$358M+55.71%
Q1 20203.14M$241M+54.92%
Q4 20192.86M$369M+55.13%
Q3 20193.14M$244M+66.10%
Q2 20193.14M$323M+67.56%
Q1 20193.14M$230M+50.43%
Q4 20183.14M$133M+41.94%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aviva Holdings Ltd.’s full portfolio or all institutional holders of MRTXEUR.